Joint Formulary & PAD

Glycopyrronium with formoterol (Bevespi Aerosphere) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Glycopyrronium with formoterol (Bevespi Aerosphere)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA LABA
Keywords :
LAMA LABA, LAMA/LABAs, LABA/LAMAs, antimuscarinic bronchodilators, respiratory
Brand Names Include :
Bevespi Aerosphere
Important Information :

This is the only LAMA/LABA available in an MDI device. Same cost as other LAMA/LABAs

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
0

Other Indications

Below are listed other indications that Glycopyrronium with formoterol (Bevespi Aerosphere) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (0)

  • No records returned.